Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids

Drug Metabolism and Disposition

Volumn 39, Issue 2, 2011, Pages 180-190

  Bui, Peter ^a,b   Imaizumi, Satoshi ^b   Beedanagari, Sudheer Reddy ^a,b   Reddy, Srinivasa T ^a,b   Hankinson, Oliver ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROPEROXYICOSATETRAENOIC ACID; 12 HYDROXYHEPTADECATRIENOIC ACID; 12 OXO EICOSATETRAENOIC ACID; 13 HYDROPEROXYARACHIDONIC ACID; 15 HYDROPEROXYARACHIDONIC ACID; 15 OXO EICOSATETRAENOIC ACID; 5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2S1; CYTOCHROME P450 3A4; ICOSANOID; MALONALDEHYDE; PROSTAGLANDIN G2; PROSTAGLANDIN H2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ARTICLE; DISEASE ASSOCIATION; HUMAN; ICOSANOID METABOLISM; METABOLISM; PRIORITY JOURNAL;

BIOTRANSFORMATION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HUMANS; LIPOXYGENASE; MICROSOMES; MOLECULAR STRUCTURE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TANDEM MASS SPECTROMETRY; TRANSFECTION;

EID: 79251516765     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.035121     Document Type: Article

References (46)

1. Altmann R, Hausmann M, Spöttl T, Gruber M, Bull AW, Menzel K, Vogl D, Herfarth H, Schölmerich J, Falk W, et al. (2007) 13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells. Biochem Pharmacol 74:612-622. (Pubitemid 47042013)
2. Antón R, Camacho M, Puig L, and Vila L (2002) Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions. J Invest Dermatol 118:139-146.
3. Barnes PJ, Rodger IW, and Thomson NC (1992) Asthma: Basic Mechanisms and Clinical Management, Academic Press, San Diego.
4. Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, and de Waziers I (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731-742.
5. Bui PH and Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031-1043.
6. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
7. Burhop KE, Selig WM, and Malik AB (1988) Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 62:687-698.
8. Capdevila JH, Vijaykumar HR, and Falck JR (2005) Cytochrome P450 and the metabolism and bioactivation of arachidonic acid and eicosanoids, in Cytochrome P450, Structure, Mechanism, and Biochemistry, 3rd ed (Ortiz de Montellano PR ed), pp 531-551, Springer US, New York.
9. Chang MS, Boeglin WE, Guengerich FP, and Brash AR (1996) Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products. Biochemistry 35:464-471. (Pubitemid 26033915)
10. Damon M, Chavis C, Daures JP, Crastes de Paulet A, Michel FB, and Godard P (1989) Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium. Eur Respir J 2:202-209. (Pubitemid 19107099)
11. Dix TA, Fontana R, Panthani A, and Marnett LJ (1985) Hematin-catalyzed epoxidation of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by polyunsaturated fatty acid hydroperoxides. J Biol Chem 260:5358-5365. (Pubitemid 15003277)
12. Gomez A, Nekvindova J, Travica S, Lee MY, Johansson I, Edler D, Mkrtchian S, and Ingelman- Sundberg M (2010) Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity. Mol Pharmacol 78:1004-1011.
13. Haeggström JZ, Rinaldo-Matthis A, Wheelock CE, and Wetterholm A (2010) Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun 396:135-139.
14. Hecker M and Ullrich V (1989) On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 264:141-150.
15. Hevko JM, Bowers RC, and Murphy RC (2001) Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel ω-oxidized metabolites in the mouse macrophage. J Pharmacol Exp Ther 296:293-305.
16. Holm KA, Park SS, Gelboin HV, and Kupfer D (1989) Monoclonal antibody-directed characterization of rat hepatic P450 catalyzing the ω-1 and ω-2 hydroxylation of prostaglandins. Arch Biochem Biophys 269:664-677.
17. Jones CE (2005) The OXE receptor: a new therapeutic approach for asthma? Trends Mol Med 11:266-270. (Pubitemid 40804789)
18. Levy BD, Clish CB, Schmidt B, Gronert K, and Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-619.
19. Mbonye UR, Wada M, Rieke CJ, Tang HY, Dewitt DL, and Smith WL (2006) The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J Biol Chem 281:35770-35778.
20. Mrsny RJ, Gewirtz AT, Siccardi D, Savidge T, Hurley BP, Madara JL, and McCormick BA (2004) Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc Natl Acad Sci USA 101:7421-7426.
21. Nebert DW and Karp CL (2008) Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem 283:36061-36065.
22. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
23. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, and Marnett LJ (2003) Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278:31426-31433.
24. Nigam S, Zafiriou MP, Deva R, Ciccoli R, and Roux-Van der Merwe R (2007) Structure, biochemistry and biology of hepoxilins: an update. FEBS J 274:3503-3512. (Pubitemid 47052415)
25. Nishida CR, Lee M, and de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497-502.
26. O'Flaherty JT, Cordes JF, Lee SL, Samuel M, and Thomas MJ (1994) Chemical and biological characterization of oxo-eicosatetraenoic acids. Biochim Biophys Acta 1201:505-515.
27. O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, and Daniel LW (1996) 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem 271:17821-17828.
28. Pace-Asciak CR (2009) The hepoxilins and some analogues: a review of their biology. Br J Pharmacol 158:972-981.
29. Patrono C, Ciabattoni G, Patrignani P, Filabozzi P, Pinca E, Satta MA, van Dorne D, Cinotti GA, Pugliese F, Pierucci A, et al. (1983) Evidence for a renal origin of urinary thromboxane B2 in health and disease. Adv Prostaglandin Thromboxane Leukot Res 11:493-498.
30. Plastaras JP, Guengerich FP, Nebert DW, and Marnett LJ (2000) Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde. J Biol Chem 275:11784-11790.
31. Powell WS, Gravel S, MacLeod RJ, Mills E, and Hashefi M (1993) Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene receptor B4. J Biol Chem 268:9280-9286.
32. Powell WS, Gravelle F, and Gravel S (1992) Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J Biol Chem 267:19233-19241.
33. Powell WS, Hashefi M, Falck JR, Chauhan K, Rokach J, Wang SS, Mills E, and MacLeod RJ (1995) Effects of oxo and dihydro metabolites of 12-hydroxy-5,8,10,14-eicosatetraenoic acid on chemotaxis and cytosolic calcium levels in human neutrophils. J Leukoc Biol 57:257-263.
34. Rivera SP, Saarikoski ST, and Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255-259. (Pubitemid 34112798)
35. Rouzer CA and Marnett LJ (2003) Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem Rev 103:2239-2304.
36. Rubin P and Mollison KW (2007) Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat 83:188-197.
37. Rylander T, Neve EP, Ingelman-Sundberg M, and Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529-535. (Pubitemid 32928187)
38. Saarikoski ST, Wikman HA, Smith G, Wolff CH, and Husgafvel-Pursiainen K (2005) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 53:549-556.
39. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343.
40. Tanaka S, Imaoka S, Kusunose E, Kusunose M, Maekawa M, and Funae Y (1990) ω- and (ω-1)-hydroxylation of arachidonic acid, lauric acid and prostaglandin A1 by multiple forms of cytochrome P-450 purified from rat hepatic microsomes. Biochim Biophys Acta 1043:177-181.
41. Van Wauwe J, Coene MC, Van Nyen G, Cools W, Le Jeune L, and Lauwers W(1992) Suggested mechanism for the formation of 15-hydroxyeicosatrienoic acid by rat epidermal microsomes. Eicosanoids 5:141-146.
42. Wang H, Marnett LJ, Harris TM, and Rizzo CJ (2004) A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. Chem Res Toxicol 17:144-149.
43. Wang SL, He XY, and Hong JY (2005) Human cytochrome P450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 33:336-340.
44. Weiss RH, Arnold JL, and Estabrook RW (1987) Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch Biochem Biophys 252:334-338.
45. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014. (Pubitemid 43894320)
46. Yeh HC, Tsai AL, and Wang LH (2007) Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases. Arch Biochem Biophys 461:159-168.